-
BeiGene and BeiZeAn are approved for new indications in the United States
Recently, BeiGene announced that the US Food and Drug Administration (FDA) has approved the use of BeiGene (Trastuzumab) in combination with platinum and fluorouracil chemotherapy for first-line trea ... -
Multiple new indications for Merck drugs approved for market in China
On December 10th, Merck announced that its PD-1 inhibitor pembrolizumab (trade name: Kelida®) Approved by the National Medical Products Administration, the combination of radiotherapy and chemoth ... -
Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
On October 26th, according to Eli Lilly, the Medicines and Medical Products Regulatory Authority (MHRA) in the UK has granted marketing authorization for its drug donanemab. Donanemab (trade name: Ki ... -
Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
According to Lilly, the Medicines and Medical Products Regulatory Authority (MHRA) in the UK has granted marketing authorization for its drug, donanemab, for Alzheimer's disease. Donanemab (trade nam ... -
Johnson&Johnson's drug Zebaike has been approved in China
On October 21st, Johnson&Johnson announced that its drug Zebeko (Nilaparivabiraterone tablets) has been officially approved by the National Medical Products Administration. As the first and only appr ... -
Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
Intel and the US government are expected to complete $8.5 billion in direct financing by the end of the year On September 27th, according to sources familiar with the matter, Intel and the US governm ... -
Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
JD Allianz Equity Transfer Approved: Allianz Insurance Group to Transfer 53.33% Equity of the Company to Allianz China Holdings
On September 5th, it was reported that the Guangdong Regulatory Bureau of the State Financial Supervision Administration approved the shareholder change application of JD Allianz Property&Casualty In ...- long_541227
- 2024-9-5 16:24
- 支持
- 反对
- 回复
- 收藏
-
The Class 1 new drug introduced by Anjin with over 1 billion US dollars has been approved for clinical use
New Beijing News (Reporter Zhang Zhaohui) On September 4th, the official website of the National Medical Products Administration announced that a new clinical application for Amgen's Class 1 new drug ... -
Tesla Musk: Expected FSD to be approved and implemented in China before the end of the year
Shanghai Securities News (reporter Yu Liyan) Elon Musk, the founder and CEO of Tesla, mentioned on the Tesla financial report conference call held on July 24 that he would apply for regulatory approv ... -
Eli Lilly and Predator Peptide Approved for Long term Weight Management Indications in China
Today, the long-term weight management indication of Eli Lilly Mufengda (Tenpo Peptide Injection) has been approved by the National Medical Products Administration. Mufengda is the first and currentl ... -
Eli Lilly AD new drug approved for market launch, lencamab meets strong competitors
On July 2nd local time, Lilly (NYSE: LLY) announced that Kisunla (donanemab, 350mg/20mL) has been approved by the US FDA for the treatment of early-stage symptoms of Alzheimer's disease (AD), includi ... -
Pricing per bottle is $695.65! Lilly AD New Drug Approved for Market, Encountering Strong Competitors with Lencamab
21st Century Business Herald reporter Han Liming reports from Shanghai On July 2nd local time, Lilly (NYSE: LLY) announced that Kisunla (donanemab, 350 mg/20 mL) has been approved by the US FDA for t ... -
The Battle of Weight Loss Drugs Begins: Smegglutide's Obesity Indications Approved in China
Recently, there has been new news in the field of GLP-1 (glucagon like peptide-1) weight loss. Novo Nordisk announced that the National Medical Products Administration (NMPA) has approved the marketi ... -
How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
Novo Nordisk Star Product Smegglutide has been approved in China for long-term weight loss management. On June 25th, Novo Nordisk announced that the National Medical Products Administration (NMPA) ha ... -
Novo Nordisk Smegglutide Injection Approved for Long Term Weight Management in China
China Securities News (reporter Li Mengyang) According to the news on June 25 on the WeChat official account of "Novo Nordisk China R&D Center", recently, the National Drug Administration (NMPA) appr ... -
Tesla Shanghai Energy Storage Super Factory Riverside Construction Plan Approved, Planned to Start Construction in May
Tesla's Shanghai Energy Storage Super Factory Riverside Construction Plan Approved and Planned to Start Construction in May. According to Tesla China, Tesla's Shanghai Energy Storage Super Factory pl ... -
Stellantis Group's € 4.7 billion dividend distribution plan approved
On April 16th local time, at the 2024 annual shareholders meeting of Stellantis Group, all proposals submitted by the group for shareholder review were approved, including the approval of a distribut ... -
Apple Vision Pro Head Display New Patent Approved: Dynamic Enhancement of "Focus Mode" Based on Surrounding Environment
According to a recent list released by the US Trademark and Patent Office (USPTO), Apple has obtained a new patent for the Vision Pro, which enhances the "focus mode" based on the dynamic enhancement ... -
After a series of twists and turns, the core product of Baekje Shenzhou, Baekze An, has become the second domestically produced PD-1 approved in the United States
After nearly two years, the BeiGene PD-1 has finally knocked on the door of the US FDA. On March 15th, Baekje Shenzhou announced that the FDA has approved the Baekje Shenzhou PD-1 inhibitor tirelizum ...